Status:
RECRUITING
China Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese Medicine
Lead Sponsor:
Dongzhimen Hospital, Beijing
Conditions:
Amyotrophic Lateral Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
A multi-center registration study of clinical characteristics of amyotrophic lateral sclerosis (ALS) patients with traditional Chinese medicine (TCM).
Detailed Description
The CARE-TCM is a prospective, multi-center, patient registry study. Eligible ALS patients with TCM treatments will be enrolled in the registry. After enrollment, this research collects the individual...
Eligibility Criteria
Inclusion
- Patients aged 18 years and older.
- Patients with possible, laboratory supported probable, probable, or definite ALS according to the revised El Escorial criteria.
- ALS patients treated with traditional Chinese medicine.
Exclusion
- Patients who refuse informed consent.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2028
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04885374
Start Date
March 1 2021
End Date
March 1 2028
Last Update
May 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dongzhimen Hospital, Beijing University of Chinese Medicine
Beijing, China, 100700